NovaTract Surgical, LLC, a New Haven, CT-based developer of a specialized surgical tool, has raised $150k in pre-seed funding.
Investors include Advantage Capital Partners and Ironwood Capital.
The company intends to use the new capital to complete the design of its tools.
Based upon technology licensed from Yale University, NovaTract was founded to develop innovative medical devices to address the field of Single-Port Laparoscopic Surgery and Natural Orifice Transluminal Endoscopic Surgery. These tools are designed to reduce postoperative pain, recovery times, and risk for complications, and improve cosmetics.
Commenting on the deal, company’s CEO Eleanor Tandler, said that the funding will give NovaTract the opportunity to continue to grow the business, and create good jobs in Connecticut.